The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 10, 2017
Filed:
Jul. 18, 2013
Applicant:
Apogenix Gmbh, Heidelberg, DE;
Inventors:
Assignee:
Apogenix AG, Heidelberg, DE;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01); G01N 33/68 (2006.01); A61K 38/17 (2006.01); A61K 45/06 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70578 (2013.01); A61K 38/177 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C07K 14/70575 (2013.01); C07K 16/2875 (2013.01); C07K 16/2878 (2013.01); G01N 33/6863 (2013.01); C07K 2319/30 (2013.01); C07K 2319/32 (2013.01); G01N 2333/70575 (2013.01); G01N 2800/22 (2013.01);
Abstract
The present invention relates to inhibitors of the CD95 signaling pathway for the use in the treatment of Myelodysplastic Syndrom (MDS) wherein the MDS is selected from the IPSS low risk MDS subgroup and/or the IPSS intermediate-1 (int-1) risk MDS subgroup as well as a method for the diagnosis of MDS.